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ABSTRACT Two isoforms of the sarcoplasmic reticulum Ca2+ release channel (ryanodine receptor or RYR) are expressed
together in the skeletal muscles of most vertebrates. We have studied physiological properties of the two isoforms (a and 1)
by comparing SR preparations from specialized fish muscles that express the a isoform alone to preparations from muscles
containing both a and ,B. Regulation of channel activity was assessed through [3H]ryanodine binding and reconstitution into planar
lipid bilayers. Distinct differences were observed in the calcium-activation and -inactivation properties of the two isoforms. The
fish a isoform, expressed alone in extraocular muscles, closely resembled the rabbit skeletal muscle RYR. Maximum [3H]-
ryanodine binding and maximum open probability (PO) of the a RYR were achieved from 1 to 10 pM free Ca2+. Millimolar Ca2+
reduced [3H]ryanodine binding and PO close to zero. The P isoform more closely resembled the fish cardiac RYR in Ca2+ activation
of [3H]ryanodine binding. The most prominent difference of the P and cardiac isoforms from the a isoform was the lack of
inactivation of [3H]ryanodine binding and PO by millimolar free Ca2+. Differences in activation of [3H]ryanodine binding by adenine
nucleotides and inhibition by Mg2+ suggest that the and cardiac RYRs are not identical, however. [3H]ryanodine binding by
the a RYR was selectively inhibited by 100 pM tetracaine, whereas cardiac and RYRs were much less affected. Tetracaine
can thus be used to separate the properties of the a and P RYRs in preparations in which both are present. The distinct
physiological properties of the a and RYRs that are present together in most vertebrate muscles support models of EC coupling
incorporating both directly coupled and Ca2+-coupled channels within a single triad junction.
INTRODUCTION
Calcium release from intracellular stores plays an important
role in metabolic regulation and signal transduction in a wide
variety of cell types. A family of proteins, the calcium release
channels or ryanodine receptors (RYRs), are central to this
process in many cells. Ryanodine receptors were first de-
scribed as the calcium release channel in skeletal muscle
sarcoplasmic reticulum (SR). They have been shown to cor-
respond to the "foot proteins" that span the gap between the
SR membrane and the T-tubule in the triad junction (Inui
et al., 1987a; Lai et al., 1988). Biochemical purification and
cloning have revealed at least three different tissue-specific
isoforms of the RYR in mammalian tissues. The RYR in
skeletal muscle is the type 1 RYR (RYR1), which is ex-
pressed primarily in skeletal muscle (Marks et al., 1989),
although a shortened transcript of RYR1 has been found in
the brain (Takeshima et al., 1993) and an immunologically
similar RYR is abundant in cerebellar Purkinje cells (Ouyang
et al., 1993). The cardiac RYR (RYR2) was initially purified
(Inui et al., 1987b; Anderson et al., 1989) and cloned (Nakai
et al., 1990; Otsu et al., 1990) from heart, but is also ex-
pressed throughout the nervous system (Kuwajima et al.,
1992). A third isoform (RYR3) has been cloned from brain
(Hakamata et al., 1992). It is expressed primarily in brain, but
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is also present in smooth muscle and some endothelial cells
(Hakamata et al., 1992).
All three RYR isoforms have structural and functional
features in common. The functional channel consists of a
homotetramer of an approximately 565 kDa polypeptide
whose cytoplasmic domains form the feet structures. The
channel is formed by the transmembrane domains of all four
subunits (Lai et al., 1989). Each of the isoforms is activated
by micromolar calcium, adenine nucleotides, caffeine, and
nanomolar ryanodine and inhibited by magnesium, ruthe-
nium red, and micromolar ryanodine (Meissner, 1994). A
number of differences, however, attest to the fact that the
RYR isoforms are not functionally equivalent. Although all
three RYR isoforms are approximately the same size, there
is only about 67% amino acid sequence identity between
them (66% skeletal and cardiac; 67% cardiac and brain; 67%
skeletal and brain; Nakai et al., 1990; Hakamata et al., 1992).
Comparisons between the cardiac and skeletal muscle iso-
forms show that the cardiac muscle RYR is more sensitive
to activation by micromolar free calcium and is less sensitive
to inhibition by millimolar calcium (Pessah et al., 1985;
Michalak et al., 1988; Chu et al., 1993). The cardiac isoform
is also more readily phosphorylated by calmodulin-
dependent protein kinase (CaM-Kinase) and cyclic AMP-
dependent protein kinase than is the skeletal isoform
(Witcher et al., 1991; Strand et al., 1993), and shows altered
conductance properties when phosphorylated (Witcher et al.,
1991).
The functional differences in RYRs may, in part, underlie
the differences in the way each RYR channel is involved in
the calcium release signal transduction pathway. Calcium
release through the cardiac muscle RYR is triggered by an
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influx of external calcium through the sarcolemmal voltage-
dependent calcium channel (dihydropyridine receptor or
DHPR) in a calcium-induced calcium release process (Stern,
1992). The skeletal muscle RYR, on the other hand, is pro-
posed to be linked mechanically to the T-tubule DHPR
(Schneider and Chandler, 1973; Rios et al., 1993) and does
not require a current of external calcium for activation. Cal-
cium release is instead proposed to be triggered by a con-
formational change in the DHPR that is directly coupled to
the skeletal RYR. The region(s) of the skeletal RYR respon-
sible for this form of coupling have not yet been identified.
In nonmammalian vertebrates, the presence of a single,
distinct isoform of each channel in cardiac and skeletal
muscle is not the rule. Most skeletal muscles of birds, fish,
amphibians, and certain reptiles express two distinct RYR
isoforms together (Airey et al., 1990; Olivares et al., 1991;
Lai et al., 1992; O'Brien et al., 1993). The isoforms, termed
a and ,B, were identified by their different mobilities on SDS
gels and differences in their immunological reactivity and
peptide maps (Airey et al., 1990; Olivares et al., 1991). The
two isoforms are detected together in the same muscle fibers
and are thought to be present in the same triad junctions
(Airey et al., 1990; Olivares et al., 1991; Lai et al., 1992).
Immunological results suggest that the a isoform in frogs,
chicken, fish, and reptiles has similarity to the mammalian
skeletal muscle RYR (Lai et al., 1992; O'Brien et al., 1993),
whereas the frog : isoform has similarity to the mammalian
cardiac muscle RYR (Lai et al., 1992; Airey et al., 1993).
Careful peptide mapping, phosphorylation, and immunologi-
cal studies in chicken have revealed that both of the RYR
isoforms in skeletal muscle are distinct from the cardiac
muscle isoform, although ,B more closely resembles the car-
diac isoform (Airey et al., 1993).
Currently, the functional significance of the coexpression
of two RYR isoforms in nonmammalian skeletal muscle re-
mains unknown. The a and f3 RYR isoforms have been
present together since the beginnings of vertebrate evolution
(O'Brien et al., 1993). A central question concerning their
presence over this 400 million year time span is this: Does
the presence of two isoforms confer physiological advan-
tages to the muscle, or is it merely an evolutionary step in
the progression to the single isoform condition seen in mam-
mals and some reptiles? To understand the functional roles
of the a and 13 RYR isoforms, it is necessary to learn how
they differ physiologically. Recently, we have studied the
distribution of RYR isoforms in skeletal muscles of a variety
of vertebrates and have discovered that the two isoforms are
differentially expressed in muscles with different functional
specializations (O'Brien et al., 1993). The a isoform is ex-
pressed alone in fish and bird extraocular muscles and the
toadfish swimbladder muscle. These muscles are unique in
that they are among the fastest-contracting muscles in ver-
tebrates. This pattern of expression has important implica-
tions for the physiological roles of the a and 3 RYR isoforms
in skeletal muscle. It suggests that the functional properties
of the a isoform are better suited for triggering high fre-
quency muscle contractions.
In the present study, we have taken advantage of the dif-
ferential expression of skeletal muscle RYR isoforms in fish
muscles to examine the physiological properties of the a and
, isoforms. We find that there are differences in the calcium
activation and inactivation properties of the two isoforms.
These physiological differences have important implications
for the properties of Ca" release at skeletal muscle triad
junctions. The distinct properties of calcium release may
likewise provide the basis on which the isoforms are selected
for use in muscles with different functional demands.
MATERIALS AND METHODS
SR isolation
Crude SR vesicles were prepared from a variety of muscle tissues from blue
marlin (Makaira nigricans) and toadfish (Opsanus tau) as previously de-
scribed (O'Brien et al., 1993). A series of SR preparations was prepared
from blue marlin muscles to allow comparison of the [3H]ryanodine binding
properties of SR from tissues with different complements of RYR isoforms.
For each blue marlin, equal quantities (5 g) of heart, superior rectus ex-
traocular muscle (containing only the a RYR isoform), and white epaxial
(swimming) muscle (containing both a and ,Bisoforms) were used to prepare
SR fractions under identical conditions. Crude SR fractions from four in-
dividual fish were prepared this way.
Heavy SR preparations more enriched in the RYR were made from toad-
fish white swimming muscle (a and 3 isoforms). Crude SR, prepared as
described above, were suspended in 0.3 M sucrose, 0.6 M KCl, 10 mM
K-piperazine-N,N'-bis[2-ethanesulfonic acid] (PIPES), pH 7.0, 100 ,uM
EGTA, 1 ,ug/ml leupeptin, 2 ,ug/ml soybean trypsin inhibitor, 1 ,ug/ml apro-
tinin, 1 mM benzamidine, and 1.2 mM diisopropylfluorophosphate (DIFP)
and layered over discontinuous sucrose gradients. The gradients consisted
of 5 ml of 45% sucrose, 8 ml of 36% sucrose, 9 ml of 30% sucrose, and
9 ml of 20% sucrose in 0.4 M KCI, 5 mM K-PIPES, pH 6.8, 100 ,LM EGTA,
100 ,uM CaC12, plus the protease inhibitors listed above. Gradients were
centrifuged for 16 h at 22,000 rpm (64,000 X gay) in a Beckman SW28 rotor,
and the heavy SR fraction collected from the 36-45% sucrose interface.
Heavy SR preparations for comparison with fish SR were made from frozen
rabbit skeletal muscle obtained from Pel-Freeze Biological Supply (Rogers,
AR).
[3H]Ryanodine binding
[3H]Ryanodine binding to SR vesicles was used as a probe for the open state
of the RYR calcium channel (Meissner, 1986; Pessah et al., 1987; Chu et al.,
1990). SR vesicles (0.2-1.0 mg protein/ml) were incubated for 6 h at 300C
in a medium consisting of (unless otherwise stated in the figure legends) 0.2
M KCl, 20 mM K-PIPES, pH 7.1, 1 mM EGTA, 2 mM nitrilotriacetic acid
(NTA), 0.5 mg/ml serum albumin, 1 g.Lg/ml leupeptin, 1 j,g/ml aprotinin, 0.6
mM DIFP, 6.4 nM [3H]ryanodine, and CaCI2 to set the free calcium con-
centration from 1 nM to 3.3 mM (pCa 9.0-2.5). Aliquots of the vesicle
suspension were filtered through Whatman GF/B filters presoaked in 5%
(w/v) polyethyleneimine and rinsed with 15 ml of ice-cold water. Radio-
activity remaining bound to the filters was measured by liquid scintillation
counting. Nonspecific binding was measured in the presence of 10 P,M
unlabeled ryanodine and was subtracted from the data to yield specifically
bound [3H]ryanodine. Data for each assay represent means for two filtered
aliquots. At least two replicate assays were performed per preparation. The
calcium concentration at the [3H]ryanodine binding peak was determined for
each preparation by analysis of the intersection of regression lines fit to
log-log plots of the binding data according to Nickerson et al. (1989). For
comparisons between tissue types, the [3H]ryanodine binding data for each
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preparation were normalized to the maximum binding measured in that
preparation. Comparisons were made at each experimental [Ca2"] using a
t-test.
Measurements of [3H]ryanodine binding affinity were performed as de-
scribed above except that the buffer contained 0.1 mg/ml BSA, 1 mM j3-y-
methyleneadenosine 5'-triphosphate (AMP-PCP), 100 ,uM free calcium,
and 1 to 100 nM [3H]ryanodine. For ryanodine concentrations higher than
10 nM, [3H]ryanodine was mixed with unlabeled ryanodine. Samples were
incubated 16 h at 30°C, and aliquots filtered through GF/B filters and treated
as above. Nonspecific binding was measured in the presence of 100 ,uM
unlabeled ryanodine.
Free calcium concentrations were calculated with a computer program
using stability constants for EGTA and NTA from Fabiato and Fabiato
(1979). The concentrations of EGTA solutions were measured by titration
with a Radiometer calcium standard using a Radiometer F2112Ca calcium
electrode. Working CaCl2 solutions were calibrated by titration with a cali-
brated EGTA solution in the same way. Protein was assayed by the Amido
Black procedure of Kaplan and Pedersen (1985).
Planar bilayer recordings
Phospholipid bilayers composed of phosphatidylethanolamine and phos-
phatidylserine (1:1 dissolved in decane to 20 mg/ml) were "painted" with
a teflon rod across an aperture of 300 ,um diameter in a delrin cup. The
cis chamber was the voltage control side connected to the head stage of a
200A Axopatch amplifier, whereas the trans side was held at virtual ground.
Agar/KCl bridges were used to connect the chambers to Ag/AgCl electrodes
immersed in 0.2 M KCl. The cis (600 ,ul) and trans (900 ,ul) chambers were
initially filled with 50 mM Cs-methanesulfonate and 10 mM Tris-HEPES,
pH 7.2. After bilayer formation, an asymmetric Cs-methanesulfonate gra-
dient (300 mM cis/50 mM trans) was established. Cs' instead of Ca2 , was
chosen as the charge carrier to precisely control Ca2 around the channel,
to increase the conductance of the channel (gCI+/gC,2+ = 2; Smith et al.,
1988), and to avoid interference from K+ channels present in the SR mem-
brane. Cl- channels were blocked by replacement of Cl- with the imper-
meant anion methanesulfonate.
Incorporation of channels was achieved as previously described
(Valdivia et al., 1992). Heavy SR from toadfish white swimming muscle (a
and ,3 isoforms) were added to the cis chamber, which corresponds to the
cytoplasmic side of the SR, whereas the trans side corresponded to the
lumenal side. Contaminant Ca2 (-4-8 ,uM) served to activate channel
openings. After visualization of the channel, the Cs-methanesulfonate con-
centration in the trans chamber was increased to 300 mM. This maneuver
greatly improved bilayer stability and prevented further vesicle insertion,
allowing recordings to be made from the same channel for 30-60 min.
Routinely, a current-voltage relationship was constructed to determine uni-
tary channel conductance. A Ca2+-EGTA mixture was added to the cis
chamber to a final concentration of 0.059:1.00 mM, respectively. The cal-
culated free Ca2 concentration was 10 nM, which was verified with a
calcium electrode using a Molecular Probes (Eugene, OR) Ca>2 calibration
kit (range 1 nM to 1 mM). Aliquots of CaCl2 and NaOH were then added
to the cis chamber to yield the specified free [Ca>2] without pH deviation.
For each [Ca>2], single-channel data were collected at steady voltages (+40
and -40 mV) for 2-5 min. Channel activity was recorded with a 16-bit
VCR-based acquisition and storage system at a 10 kHz sampling rate. Sig-
nals were analyzed after filtering with an 8-pole Bessel filter at a sampling
frequency of 1.5-2 kHz. Data acquisition and analysis were done with Axon
Instruments (Burlingame, CA) software and hardware (pClamp vS.7, Digi-
data 200 AD/DA interface).
Materials
[3H]ryanodine was purchased from NEN (Boston, MA), and unlabeled high-
purity ryanodine (99.9%) was from Calbiochem (La Jolla, CA). Other
chemicals were of reagent grade and were purchased from Sigma Chemical
Co. (St. Louis, MO).
RESULTS
Comparison of a and f8 RYR isoforms to cardiac
muscle RYR by [3H]ryanodine binding
The a isoform is expressed alone in fish extraocular muscles
(O'Brien et al., 1993). By comparing the characteristics of
the a RYR from these muscles to those of cardiac muscle
RYR and white swimming muscle (which contains both a
and f3 RYR isoforms), we observed distinct differences in the
[3H]ryanodine binding properties of the isoforms. In these
experiments, we used a series of SR preparations from marlin
superior rectus extraocular muscle (a isoform only), white
muscle (a and , isoforms), and heart. All of the preparations
displayed high-affinity [3H]ryanodine binding (Table 1) with
Kd values ranging from 3.9 to 12 nM. None of the Kd values
were significantly different from each other, although the
p value for the difference between superior rectus muscle
(a only) and white swimming muscle (a and B) was 0.062
(t-test). [3H]ryanodine binding activity in all tissues was
strongly dependent on the presence of channel activators. To
study the role of Ca>2 in channel activation, we first com-
pared the dependency of [3H]ryanodine binding on [Ca>2]
under conditions in which Ca>2 is the sole activator of the
channel. The Ca>2 activation curves of [3H]ryanodine bind-
ing for the fish muscle SR preparations are shown in Fig. 1
A-C. There were distinct differences in the Ca2' activation
and inactivation properties of [3H]ryanodine binding in the
preparations. [3H]Ryanodine binding to marlin superior rec-
tus muscle SR (a isoform only) displayed a bell-shaped de-
pendence on free Ca>2 (Fig. 1 A). Ryanodine binding was
activated with a threshold of approximately 0.1 ,uM Ca>2 and
was maximal between 10 and 100 ,uM free Ca>2 for most
preparations. The mean [3H]ryanodine binding peak was at
pCa 4.96 (5 experiments with 4 preparations). Higher con-
centrations of Ca>2 inhibited binding with 74% inactivation
at 3.3 mM (see normalized curve, Fig. 1 D). A different Ca>2
activation and inactivation profile was observed with marlin
cardiac muscle SR (Fig. 1 B). The threshold of activation was
approximately 0.1 ,uM Ca>2, but maximum ryanodine bind-
ing was reached at pCa 4.30 (4 preparations). Furthermore,
ryanodine binding was only inactivated 18% by free Ca>2 as
high as 3.3 mM. Marlin white muscle SR (Fig. 1 C), which
contain both a and , RYR isoforms, had [3H]ryanodine bind-
ing characteristics intermediate between those of the cardiac
muscle and superior rectus preparations. The peak of [3H]-
ryanodine binding was at pCa 4.28, similar to the cardiac
muscle preparations, but there was more inactivation (41%)
by 3.3 mM free Ca>2. The difference in [3H]ryanodine bind-
ing peak between the superior rectus and heart preparations
TABLE 1 [3H] Ryanodine binding properties of marlin
muscle SR preparations
Muscle (number of preparations) Kd (nM) Bmax (pmol/mg)
White muscle (a and ,B isoforms) (2) 3.87 + 0.04 3.71 ± 0.23
Superior rectus (a isoforms) (3) 9.84 ± 2.75 2.18 ± 0.79
Heart (3) 12.06 + 5.37 1.57 ± 0.63
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FIGURE 1 Calcium dependence of
[3H]ryanodine binding to SR vesicles
from marlin muscles. SR vesicles
were incubated with 6.4 nM [3H]ry-
anodine under conditions in which
Ca2" is the sole channel activator (see
Materials and Methods). (A) Superior
rectus muscle SR, containing the a
isoform only, shows a strongly bipha-
sic response to Ca2". [3H]Ryanodine
binding is nearly completely blocked
at pCa 2.5. (B) Cardiac muscle SR has
a [3H]ryanodine binding curve that is
shifted to the right and displays little
inhibition of binding at pCa 2.5. (C)
White swimming muscle SR, contain-
ing both a and a isoforms, has a [3H]-
ryanodine binding curve similar to
that of cardiac muscle SR. (D) Nor-
malized curves for the three tissues re-
veal the differences in position of the
ryanodine binding peak and degree of
inactivation at millimolar Ca2' be-
tween superior rectus (a only; 0),
heart (cardiac; A), and white swim-
ming muscle (a and ,B; 0) SR prepa-
rations. Data are means ± SE for four
preparations. Error bars have been
omitted from D for clarity.
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was statistically significant (p = 0.034), whereas a signifi-
cant difference was not established between superior rectus
and white muscle (p = 0.061). The p-value for the similarity
of [3H]ryanodine binding peak between white muscle and
heart preparations was 0.91. The degree of inactivation of
[3H]ryanodine binding at 3.3 mM free Ca2" (pCa 2.5) was
significantly different between all three preparations. [3H]-
ryanodine bound at pCa 2.5 was significantly lower in white
muscle SR than in heart (p = 0.043), and [3H]ryanodine
bound to superior rectus SR was significantly lower than to
white muscle (p = 0.024). Comparison of superior rectus
and heart yielded a p of 0.001. The similarity of the white
muscle [3H]ryanodine binding peak to that of heart as well
as the reduced inactivation at high [Ca21] compared with
superior rectus SR (with only the a isoform present) suggests
that a portion of the [3H]ryanodine binding activity in white
muscle SR has properties similar to those of the fish cardiac
RYR.
Tetracaine has differential effects on
[3H]ryanodine binding by the RYR isoforms
To discern the [3H]ryanodine binding contributions of the a
and 1B isoforms in white skeletal muscle preparations that
contain both isoforms, it is necessary to selectively activate
or inhibit the isoforms. The [3H]ryanodine binding charac-
teristics of the different types of SR preparations were modi-
fied by application of the local anesthetic tetracaine. Dose-
response curves of the effect of tetracaine on each of the
marlin muscle SR types at pCa 4.0 in the presence of 2.5 mM
AMP-PCP and 2.5 mM Mg2+ (0.4mM free Mg2+) are shown
in Fig. 2 A. The Ki values from these curves are 66 ,iM for
superior rectus (a only), 89 ,tM for white muscle (a and 1),
and 360 ,uM for heart. The heart Ki for tetracaine was sig-
nificantly higher than either superior rectus or white muscle
K1 values (p < 0.05 for both comparisons), but no statistical
difference was found between superior rectus and white
muscle Ki values. Hill plots of these data (Fig. 2 B-D) are
linear at high tetracaine concentration for all tissues, but
curved below a threshold level. The slopes of the linear por-
tion are different for each tissue type, with a slope of -1.01
t 0.05 (regression coefficient SE of determination) for
superior rectus (a isoform), -1.35 t 0.10 for heart, and
-1.29 t 0.08 for white muscle (a and 1). The slope of the
superior rectus Hill plot was significantly different than that
of either the heart or white muscle preparations (p < 0.05 for
both comparisons), but there was no significant difference
between heart and white muscle preparations. These data
reveal differential inhibition of the RYR isoforms by tetra-
caine. The a isoform, expressed alone in superior rectus
muscle, is more sensitive to tetracaine inhibition than is the
cardiac isoform. Furthermore, it appears that the isoform
in white muscle may lend some degree of insensitivity to
tetracaine, increasing the Ki and increasing the slope of the
Hill plot.
The differential inhibition of the RYR isoforms can be
seen further in experiments in which the effect of a single
tetracaine concentration was tested over the range of [Ca21]
(Fig. 3). These experiments, like those shown in Fig. 2, were
performed in the presence of 2.5 mM AMP-PCP and 2.5 mM
Mg2+ (free Mg2+ 0.2-0.5 mM) to activate [3H]ryanodine
binding. At 100 ,uM, tetracaine showed differential blocking
B
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10 8 6 4 2
(cc+P)
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FIGURE 2 Effects of tetracaine on
[3H]ryanodine binding to marlin
muscle SR. SR vesicles from superior
rectus (a only; 0), cardiac (A), and
white swimming muscle (a and 3; 0)
were incubated with varying concen-
trations of tetracaine in a medium con-
taining 2.5 mM AMP-PCP, 2.5 mM
Mg2+ (0.4 mM free Mg2+) and 100
,uM Ca2 . (A) Dose response curves
of the three SR preparations. (B-D)
Hill plots (log{bound,,/(boundcontro -
boundte)} vs. log(tetracaine concen-
tration)) of the same data for superior
rectus, cardiac, and white muscle SR
preparations.
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activity on the different muscle SR preparations, and thus can
be a useful tool to distinguish between the a and RYR
isoforms. [3H]ryanodine binding by the a isoform of superior
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rectus muscle SR preparations was inhibited more than 70%
by 100 p,M tetracaine (Fig. 3 A), whereas the shape of the
Ca2" activation curve was largely unaffected. The cardiac
FIGURE 3 Effects of 100 j.wM tet-
racaine on the Ca2" dependence of
[3H]ryanodine binding. Conditions
were similar to those in Fig. 1 except
that 2.5 mM AMP-PCP and 2.5 mM
Mg2+ were included. Specific [3H]ry-
anodine binding is increased three- to
fivefold compared with Fig. 1. Control
curves (open symbols) show [3H]ry-
anodine binding in the absence of tet-
racaine. [3H]Ryanodine binding in the
presence of 100 ,uM tetracaine is
shown with solid symbols. (A) Marlin
superior rectus muscle SR (a isoform
only). (B) Marlin cardiac muscle SR.
(C) Marlin white swimming muscle
SR (a and , isoforms). Data in A-C
are means t SDs for three determina-
tions from single preparations. (D)
Normalized control minus tetracaine-
inhibited difference curve for white
swimming muscle SR (a and ,B) shown
in C. The difference curve reveals the
Ca2' activation profile of the form pre-
dominantly inhibited by tetracaine.
Data in D are means ± SDs of the dif-
ference between paired controls and
tetracaine-inhibited preparations nor-
malized to the peak [3H]ryanodine
binding value.
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RYR isoform, on the other hand, was inhibited only 5% by
100 ,uM tetracaine (Fig. 3 B) and showed no calcium inac-
tivation under these conditions of adenylate and Mg2" modu-
lation. In the white muscle preparations, containing both a
and , RYR isoforms (Fig. 3 C), [3H]ryanodine binding was
reduced by 50% at the binding peak (100 ,uM Ca2") and
approximately 70% at 10 ,iM Ca2". An analysis of the dif-
ference between the control and tetracaine inhibited curves
for white muscle (both curves normalized to the peak of
[3H]ryanodine binding) is shown in Fig. 3 D. The difference
curve reveals a peak of tetracaine sensitivity at pCa 5, con-
sistent with the Ca2" activation profile of the a isoform. No
such consistent pattern was seen with the same treatment of
the tetracaine inhibition data of the other preparations (not
shown). These data suggest that at 100 ,iM tetracaine the a
isoform contribution to the [3H]ryanodine binding curve of
white muscle is substantially reduced. Thus, the significant
remaining [3H]ryanodine binding should reflect largely the
,B isoform contribution. The shape of the white muscle SR
[3H]ryanodine binding curve inhibited by tetracaine is very
similar to that of the uninhibited curve, supporting the con-
clusion that this shape represents primarily the (3 isoform
contribution. Comparison of this curve with the cardiac SR
[3H]ryanodine binding curve under the same conditions of
Mg2+ and adenylate demonstrates that the cardiac isoform
and the (3 isoform do not behave identically. The cardiac
isoform is maximally activated at much lower free [Ca2+]
(about 10 ,uM) than is ,B under these conditions, and shows
no evidence of inactivation by millimolar Ca2 . On the other
hand, the tetracaine-inhibited white muscle SR preparation
still shows partial inactivation by millimolar Ca2+ that is at
least partially attributable to the ( isoform.
Comparison with [3H]ryanodine binding
properties of other skeletal muscle SR
Preparations from other species show characteristics of [3H]-
ryanodine binding that match those of the marlin muscle
preparations. Heavy SR preparations from toadfish white
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muscle (a and a isoforms; Fig. 4 A) show a Ca2" activation
profile remarkably similar to that of marlin white muscle SR.
The threshold of activation is approximately 0.1 ,uM Ca2",
with maximum ryanodine binding at 100 ,uM Ca2". The in-
activation at millimolar calcium is about 30%. The Ca2" ac-
tivation profile of [3H]ryanodine binding by rabbit skeletal
muscle SR (Fig. 4 B) follows that of the marlin superior
rectus SR (a isoform alone). The Ca2" activation and inac-
tivation curves of rabbit are shifted approximately 1 pCa unit
lower, but the bell-shaped profile is preserved, with complete
inactivation of [3H]ryanodine binding at millimolar Ca".
This Ca2" activation profile was also seen in toadfish swim-
bladder muscle, in which the a isoform is present alone (Fig.
4 C). It is evident that the Ca2" activation profiles of [3H]-
ryanodine binding are consistent between species and fall
into two groupings. The fish a only preparations and mam-
malian skeletal muscle preparations form a group with a
characteristically large degree of inactivation by millimolar
Ca2". The fish white muscle preparations (a and 3isoforms)
and cardiac muscle preparations form a second group. They
differ from the a only preparations primarily in the higher
Ca2" activation peak (100 ,uM) and in the much smaller de-
gree of inactivation by millimolar Ca2". Thus, the majority
of the ryanodine binding activity by the white muscle SR has
a Ca2" activation and inactivation profile similar to that of
cardiac SR. From the results of preparations with the a iso-
form alone, it appears that the cardiac-like characteristics of
the white muscle [3H]ryanodine binding activity are con-
tributed by the ( isoform.
Functional differences of RYR isoforms
To examine further the functional differences of the toadfish
skeletal muscle RYR isoforms, we studied the single-channel
conductance and Ca2" dependence of these channels incor-
porated into planar lipid bilayers. Incorporation of heavy SR
from toadfish white muscle (a and 1B isoforms) into lipid
bilayers revealed two different high-conductance channels
with distinct properties (Fig. 5). The following controls (a)
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FIGURE 4 Calcium dependence of [3H]ryanodine binding to heavy SR preparations from other species closely resembles that of marlin SR [3H]ryanodine
binding. Heavy SR preparations were incubated under conditions identical to those in Fig. 1. (A) Toadfish white swimming muscle heavy SR, which contain
both a and ,3 RYR isoforms, have a [3H]ryanodine binding curve nearly identical to that of marlin white swimming muscle (Fig. 1 C). (B) Rabbit skeletal
muscle heavy SR have [3H]ryanodine binding characteristics very similar to those of marlin superior rectus SR (a isoform only; Fig. 1 A). The inactivation
of [3H]ryanodine binding by millimolar Ca2" is essentially complete as it was in superior rectus SR. (C) Toadfish swimbladder muscle SR, a RYR only.
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FIGURE 5 RYR isoforms of toadfish fast-twitch skeletal muscles. (A) Planar bilayer recordings of a 520 pS channel and a 380 pS channel from SR vesicles
of toadfish white skeletal muscle. Traces were obtained at specified holding potential in symmetrical 300 mM cesium methanesulfonate, 10mM Tris/HEPES,
pH 7.2. Contaminant Ca2" (4-8 ,uM) served to activate openings. Recordings were low pass-filtered at 1.5 kHz and digitized at 3 kHz. (B) Current voltage
relationship of RYR isoforms. Data were collected from four 520 pS channels and three 380 pS channels. The solid lines are linear regressions to the data
points with correlation coefficient = 0.99 for both channels.
to (d) (not shown) ensured that the recorded channel activity
corresponded to RYRs (Valdivia et al., 1992). (a) Channel
activity increased three to sixfold when 3 mM Na2ATP was
added to the cis side. (b) By contrast, similar addition of
EGTA, which decreased free Ca21 to less than 1 nM, totally
abolished channel activity. (c) Ryanodine (200 nM) irrevers-
ibly modified the kinetics and conductance of the channel,
inducing the appearance of a conductance state that repre-
sented approximately 50% of the full conductance state. And
(d) this ryanodine-modified state was completely blocked by
the addition of 5 ,lM ruthenium red to the cis chamber. Each
set of traces in Fig. 5 were taken from experiments in which
a single channel was observed. Although insertion of mul-
tiple channels occurred in about 30% of our recordings, we
analyzed only those in which a single channel was active
during the entire course of the experiment. In some instances,
we ruled out the presence of multiple channels by adding cis
5 mM ATP under optimal free [Ca21] (10-100 ,uM, see be-
low). Under these conditions, open probability (P.) was >0.3
for any given channel, and the likelihood of encountering
multiple opening levels was high. Thus, by limiting the
analysis to single-channel experiments only, we could un-
ambiguously attribute changes of activity in response to
modulators to a specific RYR isoform.
Two different RYRs were detected in toadfish white
muscle based on their single-channel conductance (Fig. 5 A).
One of the two channels had a slope conductance of 520 ±
36 pS (mean ± SD, n = 6; Fig. 5 B) and was very similar
in conductance to the RYR from rabbit skeletal muscles
(460-600 pS in monovalent solutions; Smith et al., 1988; Xu
et al., 1993). The second type of channel displayed a 380 ±
32 pS conductance and was similar in properties to the bovine
cardiac RYR (Valdivia et al., 1994). The 520 and 380 pS
channels were equally abundant in two independent prepa-
rations of SR, as judged by their frequency of presentation
in bilayer experiments (n = 14 and 11 for the 520 and 380
pS channels, respectively, from a total of 29 recordings).
Both channels displayed long, well resolved openings in-
termixed with brief, more abundant openings. Also, the pres-
ence of ultrafast components was highly likely (Tinker et al.,
1992), but the temporal resolution of our recording system
limited the detection of open events to those duration 0.50
ms and longer. For this reason, it was difficult to discern
whether truncated openings corresponded to unresolved
events or to genuine subconductance states (Liu et al., 1989).
Although all events were considered for calculation of the
channel open probability (PO) by placing the open discrimi-
nator 1 SD above the mean baseline current, we constructed
the current-voltage (I-V) relationship for both channels (Fig.
5 B) with data obtained with well resolved openings only.
The linear regression for data points thus obtained had cor-
relation coefficients .0.98.
Effects of Ca2+ on single-channel activity of
RYR isoforms
Although the 520 and 380 pS channels displayed qualita-
tively similar response to modulators, each channel dis-
played a distinct and significantly different response to Ca21.
Representative traces of channel activity of the 520 pS chan-
nel at 100 ,uM and 1 mM cis (cytoplasmic) Ca2' are shown
in Fig. 6 A, traces 1 and 2 (respectively). The 380 pS channel
at 100 ,uM and 1 mM Ca21 is shown in Fig. 6 B, traces 1 and
2. The effects of increasing cis [Ca2+] on the PO of the two
channels is shown in Fig. 6 C. The PO of both channels was
increased by 0.1-1 ,uM cis free Ca2' and achieved maximum
value between 10 and 100 puM free Ca2+. However, the two
channels displayed different responses to high [Ca21]. The
520 pS channel reached a maximum P0 of 0.31 and was
inactivated by 1 mM Ca21 (Fig. 6 A, trace 2). The 380 pS
channel was activated to nearly twice the PO, 0.57, and was
not inactivated by millimolar Ca21 (Fig. 6 B, trace 2). In both
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FIGURE 6 Ca2" dependence of open probability of RYR channels from
toadfish white swimming muscle heavy SR incorporated into planar lipid
bilayers. Two types of channels were identified in this SR preparation, which
contains both a and ,B RYR isoforms. Representative traces of the higher
conductance (520 pS) channel are shown in A. Trace 1 shows channel ac-
tivity in the presence of 10 ,uM cis (cytoplasmic) Ca21; PO = 0.22. Trace
2 shows the channel in the presence of 1 mM cis Ca21; PO = 0.04. The lower
conductance channel (380 pS) is shown in B. Trace 1 is in the presence of
10 pLM cis Ca2 , and trace 2 in the presence of 1 mM cis Ca . PO is 0.56
in trace 1 and 0.60 in trace 2. The Ca2 dependence of open probability of
the two types of channels is shown in C. Data are means SD from a total
of 14 channels.
channels, the addition of 1 mM Ca>2 caused a significant
decrease in permeability to Cs' that was reflected in the
lower current amplitude at a given holding potential (com-
pare, for example, traces 1 and 2 in Fig. 6, A and B). This
effect has been attributed to the higher selectivity of the RYR
for Ca>2 over monovalent cations (Smith et al., 1988).
In a complementary study, Valdivia et al. (1994) have
shown that the 520 pS channel was selectively activated by
Imperatoxin A, a scorpion toxin that acts selectively upon the
skeletal muscle isoform of the RYR (Valdivia et al., 1992).
The 380 pS channel was not affected. Imperatoxin A also
enhanced [3H]ryanodine binding by fish SR preparations
containing only the a isoform, whereas it increased [3H]-
ryanodine binding to fish white muscle SR preparations (a
and 13) only half as much (Valdivia et al., 1994). These data
demonstrate that the 520 pS channel activated by Impera-
toxin A is the a RYR isoform.
The Ca2' activation and inactivation of P0 closely mimic
the influences of Ca21 on [3H]ryanodine binding by the a
isoform (520 pS channel) and the cardiac isoform (380 pS
channel). Because we can identify unambiguously the 520 pS
channel as the a isoform (Valdivia et al., 1994), we know that
the a isoform shows inactivation by millimolar Ca>2 whereas
the ,B isoform does not. These results further support the
contention that the 1B isoform is largely responsible for the
relative insensitivity to inactivation by millimolar Ca>2 of
[3H]ryanodine binding by the white muscle SR.
DISCUSSION
Two ryanodine receptor isoforms, a and 3, are expressed in
similar abundance within the same skeletal muscle fibers in
most vertebrate skeletal muscles. Thus, knowledge of the
physiological properties of the a and 13 RYRs in nonmam-
malian skeletal muscle is critical for understanding the
mechanism of EC coupling. We have utilized a fish model
system that facilitates the elucidation of the [3H]ryanodine
binding properties of the two distinct nonmammalian RYR
isoforms. We have then complemented the binding studies
with observations on single-channel conductances of the two
different channels in fish swimming muscle. The expression
of the a isoform alone in fish extraocular muscles has al-
lowed us to study the a isoform in its native SR membrane
independently of the 13 isoform. Comparisons to the a + 13
population of channels in fish swimming muscles and to the
cardiac muscle RYR have then allowed us to infer [3H]-
ryanodine binding properties of the 13 isoform and to identify
unambiguously both isoforms in single-channel studies. This
approach has bypassed the need to solubilize and separately
purify the different isoforms, which may have detrimental
effects on the isolated channels' properties.
The a isoform of nonmammals is functionally
equivalent to the mammalian skeletal RYR
The a isoform, expressed alone in extraocular muscles, has
distinct and readily resolved properties of Ca` activation
and inactivation. Both [3H]ryanodine binding and single-
channel conductance studies of the a isoform reveal its bi-
phasic response to free Ca". The channel is activated at
micromolar Ca>+, with peak activation in the 1-10 AM range,
and is subsequently inhibited by millimolar Ca2+. The simi-
larity of the a RYR isoform of fish muscle to the mammalian
skeletal muscle RYR is striking. The a isoform from fish
extraocular and epaxial muscles displays similar properties
ofCa> activation and inactivation of [3H]ryanodine binding,
nearly identical single-channel conductance, and similar
Ca> activation and inactivation of channel PO to the rabbit
skeletal muscle RYR (mammalian data from Pessah et al.,
1985; Smith et al., 1986; Chu et al., 1993; fish a from this
study). These similarities of the fish a isoform to mammalian
skeletal muscle RYR were also observed in toadfish swim-
bladder muscle, a separately derived muscle that expresses
the a isoform alone. In addition to these physiological simi-
larities, the a isoform of fish and other vertebrates is the
specific target of Imperatoxin A, a scorpion toxin that se-
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lectively activates [3H]ryanodine binding and channel ac-
tivity of the mammalian skeletal muscle RYR isoform
(Valdivia et al., 1994). Finally, mammalian skeletal muscle
RYR-specific antisera recognize the fish a RYR isoform but
not the (3 isoform (O'Brien et al., 1993). These numerous
similarities indicate that the fish a RYR isoform is func-
tionally similar to the mammalian skeletal muscle RYR. In-
deed, partial sequencing of the fish a RYR has demonstrated
that its closest homology is to the mammalian skeletal muscle
RYR (Franck et al., 1994).
The p6 isoform is physiologically distinct from
the a RYR isoform
There are also similarities between the fish skeletal muscle
a RYR isoform and the cardiac muscle isoform from both
mammals and fish. Mammalian cardiac muscle RYRs are
relatively insensitive to inactivation by millimolar Ca"
when studied either with [3H]ryanodine binding (Pessah
et al., 1985; Michalak et al., 1988; Chu et al., 1993) or single-
channel recording (Rousseau et al., 1986; Chu et al., 1993),
as is the fish ( isoform. The single-channel conductance of
the toadfish ( RYR isoform is also similar to that of the
bovine cardiac RYR (Valdivia et al., 1994).-Furthermore,
both the ( isoform and the mammalian cardiac RYR are
insensitive to Imperatoxin A (Valdivia et al., 1994). How-
ever, there are certain differences that suggest that the cardiac
muscle and , isoforms are not homologous. In the presence
of AMP-PCP and Mg", the cardiac RYR is much more
sensitive to activation by Ca" than is the ( isoform (pCa for
half-maximal activation is 6.5 for cardiac, 4.7 for (3; Fig. 3,
tetracaine-modified curves). So although some properties,
especially the insensitivity to inactivation by millimolar
Ca", are similar between the cardiac and skeletal muscle (3
RYR isoforms, the two are not functionally identical. This
result is in agreement with recent biochemical studies that
distinguish between these two isoforms in chickens (Airey
et al., 1993).
Previous studies on the biochemical and physiological
properties of the skeletal muscle RYR isoforms in amphibian
muscle have also shown differences between the a and (3
isoforms in the Ca2"-dependency of channel activation.
Murayama and Ogawa (1992) purified the two isoforms from
frog muscle and found differences in their [3H]ryanodine
binding properties. The ( isoform showed a 20-fold higher
sensitivity to Ca>2 than did a, with pCa values required for
half-maximal activation of 7.1 and 5.8 for the 3and a RYRs,
respectively. These experiments were performed in a me-
dium containing 1 M NaCl and 10 mM caffeine, conditions
that potently activate the RYR, and cannot be directly com-
pared with our data. Recent molecular studies from the same
laboratories, however, confirm the physiological data linking
a- functionally with mammalian type 1 RYRs. The cDNAs
for the two RYR isoforms have been cloned and sequenced
in frog muscle (Oyamada et al., 1994) and have demonstrated
the mammalian type 1 RYR (skeletal), whereas the 3isoform
is homologous with the mammalian type 3 RYR.
A recent study of the single-channel conductance prop-
erties of the RYR channels from frog skeletal muscle (Bull
and Marengo, 1993) has revealed two distinct types of chan-
nels with very similar physiological properties to the fish a
and (3 RYR channels. One was stimulated by 10-100 ,uM
Ca" and blocked at 500 ,uM Ca", whereas the other was
stimulated by 1-10 ,uM Ca> but could not be blocked by
high [Ca"]. The blockable channels displayed about 60%
lower maximum P. than did the nonblockable channels, but
had very similar unitary conductance. The authors tentatively
identified the blockable channels as the a isoform and the
nonblockable channels as the isoform based on their dif-
ferences in sensitivity to activation by micromolar Ca> and
the relative sensitivities to Ca> of the purified a and P iso-
forms reported by Murayama and Ogawa (1992). Our results
with single channels from fish muscle SR agree with these
assignments. Thus, the physiological similarity between the
fish and frog a and RYR isoforms demonstrates that the
fundamental properties of the two isoforms are likely con-
served among the vertebrates that express both. The major
difference between the two types of nonmammalian RYRs
is in the nature of their inactivation by calcium.
Tetracaine selectively distinguishes between
the a and p6 RYR isoforms
Tetracaine has been an important tool for examining the
mechanism of EC coupling in amphibian and mammalian
muscles. Further insight into the mechanisms of Ca>2 release
in skeletal muscle may be gained from analysis of the effects
of tetracaine on the a and (3 RYR isoforms. In this study, we
have found distinct differences in the sensitivity of the fish
RYR isoforms to tetracaine. The a isoform has a ninefold
lower Ki than the cardiac isoform and a nearly twofold lower
Ki than the mixed a and pool of RYRs in fish white swim-
ming muscle. The analysis suggests that the isoform is less
sensitive to tetracaine inhibition than is the a isoform and,
indeed, at 100 ,um, tetracaine selectively inhibited [3H]ry-
anodine binding in the a RYR isoform whereas the cardiac
and isoforms were less affected. The results are consistent
with our identification of the a isoform as a functional ho-
molog of mammalian skeletal muscle RYR that is also af-
fected by tetracaine at similar concentrations (Xu et al.,
1993). We used this differential tetracaine sensitivity of
the two isoforms to provide a clearer view of the prop-
erties of the isoform in tissues that express both a and
together. By preferentially blocking the a isoform, the
(3 isoform [3H]ryanodine binding characteristics were
more easily delineated.
The selective inhibitory effect of tetracaine on [3H]ryano-
dine binding by the a RYR isoform may also be relevant to
the influence of tetracaine on Ca>2 release in skeletal muscle
fibers. Many studies have shown inhibitory effects of tetra-
caine on SR Ca>2 release (e.g., Almers and Best, 1976;
homology between the nonmammalian RYR a isoform and
O'Brien et al. 479
Csernoch et al., 1988; Pizarro et al., 1992). Pizarro et al.
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(1992) studied the effects of low concentrations of tetracaine
on the Ca2' release flux in cut frog skeletal muscle fibers. In
this study, two distinct kinetic components of the SR Ca2+
release flux with differing tetracaine sensitivities were iden-
tified. The two components of Ca2' release flux, a fast ac-
tivating and inactivating component of large amplitude and
a smaller steady release component, have been described
earlier in the literature (Simon and Schneider, 1988; Schnei-
der and Simon, 1988). Tetracaine (20 ,M) selectively in-
hibited the fast activating and inactivating component of
Ca>2 release flux, leaving the steady component unaffected
(Pizarro et al., 1992). The results indicate pharmacological
differences between the noninactivating and inactivating
components of the SR Ca2 release flux, which has been
interpreted to be a result ofdual SR Ca2' release pathways. These
results, when combined with our data indicating a selective in-
hibition of [3H]ryanodine binding to the a isoform by tetracaine,
imply that the a isoform is at least partially responsible for the
inactivating component of calcium release.
A two-component model for calcium release
in nonmammals
The presence of two RYR isoforms (a and B) with different
physiologies in most nonmammalian vertebrate skeletal
muscles has important implications for the mechanism of
Ca>2 release. Current models of skeletal muscle EC coupling
invoke a direct mechanical coupling between the voltage-
dependent, T-tubule DHPR or voltage sensor and the RYR
(type 1) as the mechanism for triggering SR Ca>2 release
(Rios et al., 1991, 1993). However, the structural model of
the triad junction, generated in toadfish swimbladder muscle
(Block et al., 1988), implies that only half of the RYRs in the
triad may be mechanically coupled to DHPRs. Importantly,
in the toadfish swimbladder muscle all RYRs are of one type,
a, which implies homology with the mammalian skeletal
muscle junction. In toadfish swimbladder muscle, RYRs that
are not coupled directly to a D4PR are presumed to couple
cooperatively with the mechanically linked RYR. A model
in which a portion of the RYRs are mechanically coupled
while others are activated secondarily by Ca>2 released by
the directly coupled channels fits logically with the physi-
ological properties of the two RYR isoforms we have iden-
tified in fish skeletal muscle. In Fig. 7 we illustrate sche-
matically a two-component model for Ca>2 release in
nonmammals based upon the results presented here as well
as the structural model of Block et al. (1988), the physi-
ological models of Rios (Rios et al., 1991, 1993), and the
results of Pizarro et al. (1992). The two component model for
Ca>2 release accommodates data that suggest that there are
two functionally separate SR Ca>2 release channels in non-
mammalian vertebrates. Voltage-sensitive channels are
gated by voltage across the T-tubular membrane, presumably
via the DHPR, whereas the other SR Ca>2 release channels
are presumed to operate by Ca2`-induced CaQ2 release. Acti-
vation of one channel by voltage would result in the release of
Ca> and thereby activate a neighboring "slave" channel. The
Two-component model of calcium release
FIGURE 7 A two component model for the calcium release process in
nonmammalian vertebrate skeletal muscle. The presence of two physiologi-
cally distinct Ca2" release channels in skeletal muscle of nonmammalian
vertebrates suggests a model in which two different forms of EC coupling
are present. Direct, mechanically coupled channels are depicted making
contact with the overlying T-tubule DHP receptor, which acts as a voltage
sensor. Ca2" release in a depolarization-induced coupling event triggers
Ca2' release from the close neighbor or "slave" RYR channel. The skeletal-
like a RYR isoform occupies the directly coupled position (see discussion),
and the 13RYR isoform the Ca2+-coupled position. The physical dimensions
of the RYR array in toadfish triad junctions are such that adjacent RYRs may
actually touch one another (Block et al., 1988) and deliver localized Ca2+
currents or transmit conformational changes.
extremely small distance between neighboring RYRs in a triad
(-30 nm between the centers of adjacent RYRs; Block et al.,
1988) would allow for tight physiological coupling of the two
types of channels.
Our results indicate that in a two-component model the a
RYR isoform is likely to be the RYR isoform directly
coupled to the DHPR. This assignment is based on two re-
sults. The a isoform is present alone in toadfish swimbladder
muscle (O'Brien et al., 1993), in which the structural evi-
dence for direct coupling was obtained (Block et al., 1988),
and it is physiologically homologous to the mammalian skel-
etal muscle RYR (Fig. 4, B and C), which is proposed to be
directly coupled. The ,B isoform is a logical candidate to be
the calcium-coupled RYR isoform because it has functional
similarity to the cardiac RYR, which operates by Ca2+-
induced Ca> release.
The dual nature of Ca>2 release suggested by the bio-
chemical, immunological, and structural properties of fish
triad junctions has numerous parallels in physiological stud-
ies of Ca>2 release in voltage-clamped single cut frog muscle
fibers (Schneider and Simon, 1988; Simon and Schneider,
1988; Jacquemond et al., 1991; Csernoch et al., 1993; Jong
et al., 1993). These studies report the existence of two com-
ponents of SR Ca>2 release, a fast activating and inactivating
component of large amplitude, and a smaller steady release
component. The interpretation of the mechanism underlying
these two components is controversial. Some authors report
that the inactivating component is selectively eliminated by
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fast Ca2+ buffers (BAPTA and Fura 2) and interpret it as
representing a CICR component that is rapidly Ca>2-
inactivated (Jacquemond et al., 1991; Csernoch et al., 1993).
The remaining steady release is believed to represent a di-
rectly coupled component of Ca>2 release. A number of other
studies have reported contradictory results. Baylor and
Hollingworth (1988), Hollingworth et al. (1992), Pape et al.
(1993), and Jong et al. (1993) report an enhancement of the
Ca>2 release rate by Ca>2 buffers, suggesting a role for Ca>2
inactivation of Ca>2 release, but not supporting the evidence
for Ca21-induced Ca2+ release. Significant differences in the
rates of Ca>2 release reported and the methods used make it
difficult to reconcile the conflicting reports.
One property of the Ca>2 release flux experiments is
agreed upon: the fast inactivating component is inactivated
by Ca>2. The tetracaine sensitivity of the inactivating com-
ponent observed by Pizarro et al. (1992) in whole fiber stud-
ies and the tetracaine sensitivity of the a RYR isoform in
isolated SR vesicles shown in this study suggest that the fast
inactivating component is at least partially attributable to the
a RYR isoform. This is corroborated by the inhibition of [3H]-
ryanodine binding and reduction in channel PO of the a isoform
by high concentrations of free Ca>. The observed properties
allow for a Ca>2 release channel that can inactivate when re-
leased Ca2+ reaches millimolar levels in the restricted space of
the triad junction. Given the earlier conclusion that the a isoform
is the directly coupled RYR, our model suggests that the directly
coupled isoform may also be the Ca2+-inactivating isoform.
It is clearly difficult to equate the two components of Ca>2
release observed in whole muscle fiber experiments with the
two different channel isoforms observed in isolated vesicles.
However, an attempt to synthesize the results may be a step
forward in resolving Ca>2 release events in nonmammalian
muscles. Our model of SR Ca>2 release places the a isoform
in a directly coupled position. No direct evidence exists to
exclude other models invoking, e.g., a cooperative physical
interaction between adjacent RYRs, and one cannot exclude
direct coupling of both a and ,B RYRs to the DHPRs. The
physiological data from whole fibers suggest that the RYR
isoforms are tightly linked. Elucidation of the mode of cou-
pling by either RYR isoform to the DHPR and of the nature
of the cooperative interactions between RYRs remains an
important problem in EC coupling.
If the RYRs in all vertebrate triad junctions are coopera-
tively coupled to each other, the question arises: Why have
two different RYR isoforms? The answer to this question is
not clear, but there is evidence of evolutionary selection in
the expression patterns of nonmammalian skeletal muscles
for a and 13 isoforms together versus a alone. In an earlier
study, we found that the fish and bird muscles that expressed
the a isoform alone were specialized for high frequency con-
traction (O'Brien et al., 1993). The most prominent differ-
ence that we have observed in this study between the a and
13 RYR isoforms is the sensitivity of the a isoform to inac-
tivation by high [Ca>2]. Calcium inactivation of all of the
RYRs in a triad may produce a Ca>2 release event of shorter
duration compared to that produced by a triad with some
inactivating and some noninactivating channels. Such a short
Ca2" release spike may enable the fiber to activate more
quickly to a subsequent stimulation.
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